Joshua Arbesman

Dr. Joshua Arbesman


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YSYu Sun
Yu Sun
XLXin Li
Xin Li
CYChengqian Yin
Chengqian Yin
JZJudy Zhang
Judy Zhang
ELErshang Liang
Ershang Liang
SCShuyang Chen
Shuyang Chen
Inherited genetic variations in the melanocortin-1 receptor (MC1R) responsible for human red hair color (RHC) variants are associated with impaired DNA damage repair and increased melanoma risk. MC1R signaling is critically dependent on palmitoylation, primarily mediated by the protein acyltransferase zinc finger DHHC-type palmitoyltransferase 13 (ZDHHC13). A better understanding of how ZDHHC13 is physiologically activated could help identify approaches to prevent melanomagenesis in redheads. Here, we report that AMP-activated protein kinase (AMPK) phosphorylates ZDHHC13 at S208 to strengthen the interaction between ZDHHC13 and MC1R-RHC, leading to enhanced MC1R palmitoylation in redheads. Consequently, phosphorylation of ZDHHC13 by AMPK increased MC1R-RHC downstream signaling. AMPK activation and MC1R palmitoylation repressed UVB-induced transformation of human melanocytes in vitro and delayed melanomagenesis in vivo in C57BL/6J-MC1R-RHC mice. The importance of AMPK to MC1R signaling was validated in human melanomas where AMPK upregulation correlated with expression of factors downstream from MC1R signaling and with prolonged patient survival. These findings suggest AMPK activation as a promising strategy to reduce melanoma risk, especially for individuals with red hair. Significance: Phosphorylation of ZDHHC13 by AMPK at S208 promotes MC1R activation and suppresses melanocyte transformation, indicating activation of AMPK as a potential approach to prevent melanoma in people with red hair.

22 May 2025 in NEJM AI
Verified
Journal Article
Closed access
ACAlbert S. Chiou
Albert S. Chiou
JOJesutofunmi A. Omiye
Jesutofunmi A. Omiye
HGHaiwen Gui
Haiwen Gui
SSSusan M. Swetter
Susan M. Swetter
JKJustin M. Ko
Justin M. Ko
RNRoberto A. Novoa
Roberto A. Novoa

18 November 2025 in JAMA
Verified
Journal Article
Closed access
GIGideon Idumah
Gideon Idumah
DNDaphne Newell
Daphne Newell
MHMadeleine Hadrys
Madeleine Hadrys
IRIsabella Ribaudo
Isabella Ribaudo
YNYing Ni
Ying Ni
JAJoshua Arbesman
Joshua Arbesman
This cross-sectional analysis uses data from the All of Us study to estimate the population-level prevalence in US adults of pathogenic variants in key cancer susceptibility genes.

Verified
Journal Article
Open access
PDF file
DGDaniel Gutierrez
Daniel Gutierrez
JAJoshua Arbesman
Joshua Arbesman
Circadian rhythms are core regulators of a variety of mammalian physiologic processes and oscillate in a 24-h pattern. Many peripheral organs possess endogenous rhythmicity that is then modulated by a master clock; the skin is one of these peripheral organs. The dysregulation of rhythms is associated with decreased ability to ameliorate cellular stressors at a local and global level, which then increases the propensity for the development of neoplastic growths. In this article, we review the implications of altered circadian rhythms on DNA repair as well as modified gene expression of core clock proteins with particular focus on skin models. These findings are then correlated with epidemiologic data regarding skin cancer to showcase the effects of circadian disruption on this phenomenon.

9 May 2020 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
PDF file
JSJingfeng Sha
Jingfeng Sha
JAJoshua Arbesman
Joshua Arbesman
MHMarian L. Harter
Marian L. Harter

5 December 2017 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
RCRuzica Z. Conic
Ruzica Z. Conic
JAJoshua Arbesman
Joshua Arbesman